Antifungal canthin-6-one series accumulate in lipid droplets and affect fatty acid metabolism in Saccharomyces cerevisiae

Biomed Pharmacother. 2008 Feb;62(2):99-103. doi: 10.1016/j.biopha.2007.07.014. Epub 2007 Aug 23.

Abstract

The mechanism of action of antifungal canthin-6-one series was investigated in Saccharomyces cerevisiae. After a rapid uptake, a preferential accumulation of the drug within lipid droplets was observed. The antifungal action of canthin-6-one was found as reversible. Canthin-6-one did not exhibit affinity for sterols, and membrane ergosterol was not necessary for the antifungal activity since the MICs were similar on an ergosterol-deleted and the wild-type S. cerevisiae clones. Relative amount of unsaturated alkyl chain fatty acids was significantly enhanced suggesting a stimulation of desaturase enzyme systems. No synergistic effect was observed between canthin-6-one and amphotericin B, ketoconazole and caspofungine. Canthin-6-one should now be evaluated in vivo against fungal pathogens.

Publication types

  • Comparative Study

MeSH terms

  • Amphotericin B / pharmacology
  • Antifungal Agents / isolation & purification
  • Antifungal Agents / pharmacokinetics
  • Antifungal Agents / pharmacology*
  • Carbolines
  • Drug Synergism
  • Fatty Acid Desaturases / drug effects
  • Fatty Acid Desaturases / metabolism
  • Fatty Acids / metabolism
  • Indole Alkaloids
  • Indoles / isolation & purification
  • Indoles / pharmacology*
  • Ketoconazole / pharmacology
  • Microbial Sensitivity Tests
  • Naphthyridines / isolation & purification
  • Naphthyridines / pharmacology*
  • Saccharomyces cerevisiae

Substances

  • Antifungal Agents
  • Carbolines
  • Fatty Acids
  • Indole Alkaloids
  • Indoles
  • Naphthyridines
  • canthin-6-one
  • Amphotericin B
  • Fatty Acid Desaturases
  • Ketoconazole